STOCK TITAN

AMAZE HOLDINGS (AMZE) 424B Filings

AMZE OTC

Here are the 424B prospectus supplements from AMAZE HOLDINGS INC (AMZE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow AMZE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMZE filings page.

Rhea-AI Summary

Amaze Holdings, Inc. (AMZE) registered up to 50,000,000 shares of common stock for resale by C/M Capital Master Fund, LP. The shares may be issued to the fund under an equity line that lets Amaze choose, subject to contract conditions, whether to sell shares during a 36-month term beginning when applicable conditions are satisfied. Amaze may receive up to $100 million in gross proceeds from those initial sales; it receives no proceeds from the fund’s later resales.

Fixed and VWAP purchases require the prior business day’s closing price to be at least $0.01; fixed purchases are limited to $500,000 each and $10 million in aggregate per day. Purchase prices are 95% of specified lower-of market-price benchmarks. Separately, the $2 million commitment fee is payable in 1,000,000 Series F preferred shares convertible into up to 80,000,000 common shares at $0.025 per share, subject to ownership limits and conversion restrictions.

Amaze’s common stock was delisted from NYSE American effective October 12, 2026, and management reported material weaknesses in internal controls as of December 31, 2025. The prospectus says equity-line issuances would dilute existing holders and significant resales could pressure the share price.

Rhea-AI Summary

Amaze Holding Company (AMZE) proposes an additional $31,839,162 of common stock for sale under an existing at-the-market Sales Agreement with Ladenburg Thalmann. Through the agreement the company previously sold $9,430,968.92 of shares. The prospectus supplement ties the assumed offering price to the last reported sale price of $0.1866 per share on March 30, 2026 and uses December 31, 2025 balance sheet metrics for dilution calculations.

The filing reports historical net tangible book value of $(19,923,175) or $(0.63) per share and as-adjusted net tangible book value of $10,935,812 or $0.05 per share after the illustrative $31,839,162 raise, implying immediate dilution of $0.14 per share to new investors. Shares outstanding used for the illustration: 31,470,900 as of December 31, 2025. The supplement also discloses expected non‑cash goodwill impairment of up to $34.0M, preliminary 2025 net revenues of $2.0M and a preliminary net loss of $55.0M.

Rhea-AI Summary

Amaze Holdings, Inc. registered up to 50,000,000 shares of common stock for resale by C/M Capital Master Fund, LP (the Selling Stockholder) pursuant to a committed equity financing arrangement.

The registration covers up to 49,625,000 Purchase Shares issuable under a Purchase Agreement (an equity line) and up to 375,000 Commitment Shares. The Purchase Agreement was amended to cap gross proceeds to $25,000,000 and the company previously received $9,442,813 from sales in 2025. Sales to the Selling Stockholder are at the company’s election, subject to a 4.99% beneficial ownership limit (expandable to 9.99% with notice), a Floor Price of $0.20, and other conditions; the company will not receive proceeds from resales by the Selling Stockholder.

Rhea-AI Summary

Amaze Holdings, Inc. has filed a resale prospectus covering up to 5,524,316 shares of common stock issuable upon conversion of senior secured original issue discount convertible promissory notes with outstanding principal of $4,143,234.25.

Only the selling stockholders may sell these shares, and Amaze will not receive any proceeds from their resale, though share issuance upon conversion reduces cash otherwise payable on the notes. The registration covers 200% of the shares currently issuable at a $1.50 floor price, and share issuances are capped at 19.9% of outstanding common stock as of September 11, 2025 without prior stockholder approval. Amaze operates two segments—creator-focused e-commerce/subscriptions and “better-for-you” wine products—and qualifies as both an emerging growth company and a smaller reporting company.

Rhea-AI Summary

AMZE is amending its at-the-market program to offer an additional $18,106,838 of common stock through Ladenburg Thalmann under an existing sales agreement. The assumed price used for dilution calculations is $0.2715 per share, which was the last reported sale price on the NYSE American on November 20, 2025.

As of September 30, 2025, historical net tangible book value was approximately $(26,016,789), or $(4.06) per share. After giving effect to this additional ATM capacity, as adjusted net tangible book value would have been about $(8,553,156), or $(0.12) per share. This implies an immediate increase in net tangible book value of $3.94 per share for existing stockholders and immediate dilution of $0.39 per share for new investors.

The dilution analysis is based on 6,410,742 shares outstanding as of September 30, 2025 and does not reflect potential further dilution from convertible preferred stock, convertible notes, warrants or future equity or convertible debt financing.